Healthcare
CVC acquires Synsam
Sale process launched in 2012
Nextech hires ex-Centrum Bank CEO as new partner
Lips also held roles at Falcon Private Bank and Goldman Sachs
VC-backed Horizon Discovery raises £68.6m for IPO
Offering gives company ТЃ120.5m market cap
ZernikeMeta et al. invest €2m in CellPly
The company is developing in-vitro cancer treatments
Ysios Capital launches second fund
VC targeting €100m for life sciences fund
VC firms exit Activaero in trade sale
€130m proceeds to be split between cash and shares
EdRip, Sofinnova lead €18m round for Inotrem
Biomed Invest and Inserm Transfert Initiative also take part
VC-backed Circassia valued at £581m for IPO
Largest LSE IPO of VC- or PE-backed UK healthcare company in decade
Deal in focus: Montagu enters Dutch market with Dorc purchase
Ophthalmic surgery instruments producer generates €80m turnover
LSP closes Health Economics Fund on €112m
Vehicle began investing in September 2012
Montagu acquires Arkopharma
Pythotherapy business generates €200m turnover
High-Tech Gründerfonds invests in Desino
Business angel joins to complete first financing round
Demeter and Emertec inject €1.8m into Ynsect
French biotech operates large-scale insect farm
Deal in focus: GC Aesthetics receives $60m lift
Management targeting 30% growth per annum
VC-backed Horizon Discovery plans £25m IPO
Horizon Discovery Group, a Cambridge-based biotech backed by DFJ Esprit and Roche Venture Fund among others, is planning to raise ТЃ25m in its IPO on the AIM segment of the London Stock Exchange.
CEA Investissement leads €2m round for Microphyt
CEA Investissement, Sofimac Partners and Soridec have taken part in a €2m funding round for Microphyt, a French biotech specialising in microalgae-based bioactive products.
Innovation Capital holds first close on €40m
Innovation Capital has held the first close for its Services Innovants Santé et Autonomie (SISA) fund, a vehicle aimed at the “silver economy”, on €40m.
NeoMed leads €15m round for InDex Pharmaceuticals
Venture capital firm NeoMed Management has led a тЌ15m investment in Swedish drug developer InDex Pharmaceuticals via a new rights issue.
Percipient Capital backs Elucigene MBO
Percipient Capital has supported the management buyout of Elucigene Diagnostics, the UK-based arm of Hologic, a US-based healthcare diagnostics firm.
Beringea backs DCC with £3m
Beringea has invested ТЃ3m in Disposable Cubicle Curtains (DCC), a UK-based manufacturer of disposable curtains for hospitals that trades under All In One Medical.
Cinven, EQT target new geographies
European buyout houses Cinven and EQT have been looking further afield for healthcare investments, this week buying US-based CRO business Medpace and Australian radiology specialist I-Med, respectively.
Montagu acquires Dorc from Rabo Capital
Montagu Private Equity has acquired Dutch Ophthalmic Research Center (Dorc) from Rabo Capital, the private equity division of Rabo Bank.
Boehringer Ingelheim leads early-stage round for Amal
Boehringer Ingelheim Venture Fund (BIVF) and High-Tech Gründerfonds have invested in a seed-funding round for Swiss biotech start-up Amal Therapeutics.
Covagen extends series-B with Baxter investment
Swiss biotech Covagen has extended its CHF 42m series-B funding round, raised in December, to procure a further CHF 2.9m from Baxter Ventures.